{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["H1N1/human coronavirus", "antiviral", "ellagic acid", "nanoformulation/delivery system", "natural agents", "zinc oxide nanoparticles"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34959455", "DateRevised": {"Year": "2024", "Month": "04", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "16"}], "Language": ["eng"], "ELocationID": ["2174", "10.3390/pharmaceutics13122174"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "13", "Issue": "12", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "16"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Nanoformulation Composed of Ellagic Acid and Functionalized Zinc Oxide Nanoparticles Inactivates DNA and RNA Viruses.", "Abstract": {"AbstractText": ["The COVID-19 pandemic has strongly impacted daily life across the globe and caused millions of infections and deaths. No drug therapy has yet been approved for the clinic. In the current study, we provide a novel nanoformulation against DNA and RNA viruses that also has a potential for implementation against COVID-19. The inorganic-organic hybrid nanoformulation is composed of zinc oxide nanoparticles (ZnO NPs) functionalized with triptycene organic molecules (TRP) via EDC/NHS coupling chemistry and impregnated with a natural agent, ellagic acid (ELG), via non-covalent interactions. The physicochemical properties of prepared materials were identified with several techniques. The hybrid nanoformulation contained 9.5 wt.% TRP and was loaded with up to 33.3 wt.% ELG. ELG alone exhibited higher cytotoxicity than both the ZnO NPs and nanoformulation against host cells. The nanoformulation efficiently inhibited viruses, compared to ZnO NPs or ELG alone. For H1N1 and HCoV-229E (RNA viruses), the nanoformulation had a therapeutic index of 77.3 and 75.7, respectively. For HSV-2 and Ad-7 (DNA viruses), the nanoformulation had a therapeutic index of 57.5 and 51.7, respectively. In addition, the nanoformulation showed direct inactivation of HCoV-229E via a virucidal mechanism. The inhibition by this mechanism was > 60%. Thus, the nanoformulation is a potentially safe and low-cost hybrid agent that can be explored as a new alternative therapeutic strategy for COVID-19."]}, "AuthorList": [{"Identifier": ["0000-0001-8413-6738"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska St. 29/37, 01-142 Warsaw, Poland."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre (NRC), 33 El-Behouth St., Dokki, Giza 12622, Egypt."}], "LastName": "AbouAitah", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": ["0000-0003-1550-4140"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Environmental Virology Laboratory, Water Pollution Research Department, Environment and Climate Change Institute, National Research Centre (NRC), 33 El-Behouth St., Dokki, Giza 12622, Egypt."}], "LastName": "Allayh", "ForeName": "Abdou K", "Initials": "AK"}, {"Identifier": ["0000-0002-6106-5188"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska St. 29/37, 01-142 Warsaw, Poland."}], "LastName": "Wojnarowicz", "ForeName": "Jacek", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Institute, National Research Centre (NRC), 33 El-Behouth St., Dokki, Giza 12622, Egypt."}], "LastName": "Shaker", "ForeName": "Yasser M", "Initials": "YM"}, {"Identifier": ["0000-0001-6993-1741"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska St. 29/37, 01-142 Warsaw, Poland."}], "LastName": "Swiderska-Sroda", "ForeName": "Anna", "Initials": "A"}, {"Identifier": ["0000-0001-8521-0688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska St. 29/37, 01-142 Warsaw, Poland."}], "LastName": "Lojkowski", "ForeName": "Witold", "Initials": "W"}], "GrantList": [{"GrantID": "CePT project (No. POIG.02.02.00-14-024/08)", "Agency": "Funding for the equipment used in this research under the European Regional Development Fund within the Operational Program \"Innovative Economy\" for 2007-2013.", "Country": ""}, {"Agency": "The National Research Centre (Egypt) and the Institute of High-Pressure Physics, Polish Academy of Sciences (Poland), supported this work by using the chemicals, re-agents, and devices available at the laboratories.", "Country": ""}, {"Agency": "The APC was funded by the Institute of High-Pressure Physics, Polish Academy of Sciences (Poland).", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Vecitis C.D. Antiviral-nanoparticle interactions and reactions. Environ. Sci. Nano. 2021;8:11\u201319. doi: 10.1039/D0EN00980F.", "ArticleIdList": ["10.1039/D0EN00980F"]}, {"Citation": "Tharayil A., Rajakumari R., Kumar A., Choudhary M.D., Palit P., Thomas S. New insights into application of nanoparticles in the diagnosis and screening of novel coronavirus (SARS-CoV-2) Emergent. Mater. 2021;4:101\u2013117. doi: 10.1007/s42247-021-00182-w.", "ArticleIdList": ["10.1007/s42247-021-00182-w", "PMC8010296", "33817553"]}, {"Citation": "Mei M., Tan X. Current Strategies of Antiviral Drug Discovery for COVID-19. Front. Mol. Biosci. 2021;8:310. doi: 10.3389/fmolb.2021.671263.", "ArticleIdList": ["10.3389/fmolb.2021.671263", "PMC8155633", "34055887"]}, {"Citation": "Yang K.C., Lin J.C., Tsai H.H., Hsu C.Y., Shih V., Hu C.J. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: Multipronged therapeutic intervention for pandemic control. Drug Deliv. Transl. Res. 2021;11:1420\u20131437. doi: 10.1007/s13346-021-00965-y.", "ArticleIdList": ["10.1007/s13346-021-00965-y", "PMC7982277", "33748879"]}, {"Citation": "Shah S., Chougule M.B., Kotha A.K., Kashikar R., Godugu C., Raghuvanshi R.S., Singh S.B., Srivastava S. Nanomedicine based approaches for combating viral infections. J. Control. Release. 2021;338:80\u2013104. doi: 10.1016/j.jconrel.2021.08.011.", "ArticleIdList": ["10.1016/j.jconrel.2021.08.011", "PMC8526416", "34375690"]}, {"Citation": "Jamalipour Soufi G., Iravani S. Nanomaterials against pathogenic viruses: Greener and sustainable approaches. Inorg. Nano-Met. Chem. 2021;51:1598\u20131614. doi: 10.1080/24701556.2020.1852252.", "ArticleIdList": ["10.1080/24701556.2020.1852252"]}, {"Citation": "Sadique M.A., Yadav S., Ranjan P., Verma S., Salammal S.T., Khan M.A., Kaushik A., Khan R. High-performance antiviral nano-systems as a shield to inhibit viral infections: SARS-CoV-2 as a model case study. J. Mater. Chem. B. 2021;9:4620\u20134642. doi: 10.1039/D1TB00472G.", "ArticleIdList": ["10.1039/D1TB00472G", "34027540"]}, {"Citation": "Innocenzi P., Stagi L. Carbon-based antiviral nanomaterials: Graphene, C-dots, and fullerenes. A perspective. Chem. Sci. 2020;11:6606\u20136622. doi: 10.1039/D0SC02658A.", "ArticleIdList": ["10.1039/D0SC02658A", "PMC7499860", "33033592"]}, {"Citation": "AbouAitah K., Swiderska-Sroda A., Kandeil A., Salman A.M.M., Wojnarowicz J., Ali M.A., Opalinska A., Gierlotka S., Ciach T., Lojkowski W. Virucidal Action against Avian Influenza H5N1 Virus and Immunomodulatory Effects of Nanoformulations Consisting of Mesoporous Silica Nanoparticles Loaded with Natural Prodrugs. Int. J. Nanomed. 2020;15:5181\u20135202. doi: 10.2147/IJN.S247692.", "ArticleIdList": ["10.2147/IJN.S247692", "PMC7398888", "32801685"]}, {"Citation": "Ghaffari H., Tavakoli A., Moradi A., Tabarraei A., Bokharaei-Salim F., Zahmatkeshan M., Farahmand M., Javanmard D., Kiani S.J., Esghaei M., et al. Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: Another emerging application of nanomedicine. J. Biomed. Sci. 2019;26:70. doi: 10.1186/s12929-019-0563-4.", "ArticleIdList": ["10.1186/s12929-019-0563-4", "PMC6734352", "31500628"]}, {"Citation": "Jaros S.W., Kr\u00f3l J., Ba\u017can\u00f3w B., Poradowski D., Chr\u00f3szcz A., Nesterov D.S., Kirillov A.M., Smole\u0144ski P. Antiviral, Antibacterial, Antifungal, and Cytotoxic Silver(I) BioMOF Assembled from 1,3,5-Triaza-7-Phoshaadamantane and Pyromellitic Acid. Molecules. 2020;25:2119. doi: 10.3390/molecules25092119.", "ArticleIdList": ["10.3390/molecules25092119", "PMC7249189", "32369972"]}, {"Citation": "Galdiero S., Falanga A., Vitiello M., Cantisani M., Marra V., Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16:8894\u20138918. doi: 10.3390/molecules16108894.", "ArticleIdList": ["10.3390/molecules16108894", "PMC6264685", "22024958"]}, {"Citation": "AbouAitah K., Piotrowska U., Wojnarowicz J., Swiderska-Sroda A., El-Desoky A.H.H., Lojkowski W. Enhanced Activity and Sustained Release of Protocatechuic Acid, a Natural Antibacterial Agent, from Hybrid Nanoformulations with Zinc Oxide Nanoparticles. Int. J. Mol. Sci. 2021;22:5287. doi: 10.3390/ijms22105287.", "ArticleIdList": ["10.3390/ijms22105287", "PMC8156785", "34069756"]}, {"Citation": "Zhang Q., Luo S., Weidman J., Guo R. Surface modification of ZIF-90 with triptycene for enhanced interfacial interaction in mixed-matrix membranes for gas separation. J. Polym. Sci. 2020;58:2675\u20132687. doi: 10.1002/pol.20200123.", "ArticleIdList": ["10.1002/pol.20200123"]}, {"Citation": "Moylan C., Rogers L., Shaker Y.M., Davis M., Eckhardt H.-G., Eckert R., Ryan A.A., Senge M.O. Preparation of Tri- and Hexasubstituted Triptycene Synthons by Transition Metal Catalyzed Cross-Coupling Reactions for Post-Modifications. Eur. J. Org. Chem. 2016;2016:185\u2013195. doi: 10.1002/ejoc.201501272.", "ArticleIdList": ["10.1002/ejoc.201501272"]}, {"Citation": "Chong J.H., Ardakani S.J., Smith K.J., MacLachlan M.J. Triptycene-Based Metal Salphens\u2014Exploiting Intrinsic Molecular Porosity for Gas Storage. Chem.\u2014Eur. J. 2009;15:11824\u201311828. doi: 10.1002/chem.200902188.", "ArticleIdList": ["10.1002/chem.200902188", "19839019"]}, {"Citation": "Nikitin K., M\u00fcller-Bunz H., Ortin Y., Muldoon J., McGlinchey M.J. Molecular Dials: Hindered Rotations in Mono- and Diferrocenyl Anthracenes and Triptycenes. J. Am. Chem. Soc. 2010;132:17617\u201317622. doi: 10.1021/ja108226p.", "ArticleIdList": ["10.1021/ja108226p", "21090624"]}, {"Citation": "Finnigan E.M., Rein R., Solladi\u00e9 N., Dahms K., G\u00f6tz D.C.G., Bringmann G., Senge M.O. Synthesis and ligand binding properties of triptycene-linked porphyrin arrays. Tetrahedron. 2011;67:1126\u20131134. doi: 10.1016/j.tet.2010.12.025.", "ArticleIdList": ["10.1016/j.tet.2010.12.025"]}, {"Citation": "Jacquot\u2005de\u2005Rouville H.-P., Garbage R., Cook R.E., Pujol A.R., Sirven A.M., Rapenne G. Synthesis of Polycyclic Aromatic Hydrocarbon-Based Nanovehicles Equipped with Triptycene Wheels. Chem.\u2014Eur. J. 2012;18:3023\u20133031. doi: 10.1002/chem.201102893.", "ArticleIdList": ["10.1002/chem.201102893", "22298414"]}, {"Citation": "Rogerio A.P., Fontanari C., Borducchi E., Keller A.C., Russo M., Soares E.G., Albuquerque D.A., Faccioli L.H. Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. Eur. J. Pharm. 2008;580:262\u2013270. doi: 10.1016/j.ejphar.2007.10.034.", "ArticleIdList": ["10.1016/j.ejphar.2007.10.034", "18021768"]}, {"Citation": "Bell C., Hawthorne S. Ellagic acid, pomegranate and prostate cancer\u2014A mini review. J. Pharm. Pharm. 2008;60:139\u2013144. doi: 10.1211/jpp.60.2.0001.", "ArticleIdList": ["10.1211/jpp.60.2.0001", "18237460"]}, {"Citation": "Kang E.H., Kown T.Y., Oh G.T., Park W.F., Park S.I., Park S.K., Lee Y.I. The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B viruse antigen. Antivir. Res. 2006;72:100\u2013106. doi: 10.1016/j.antiviral.2006.04.006.", "ArticleIdList": ["10.1016/j.antiviral.2006.04.006", "16720052"]}, {"Citation": "Pavlova E.L., Zografov N.N., Simeonova L.S. Comparative study on the antioxidant capacities of synthetic influenza inhibitors and ellagic acid in model systems. Biomed. Pharm. 2016;83:755\u2013762. doi: 10.1016/j.biopha.2016.07.046.", "ArticleIdList": ["10.1016/j.biopha.2016.07.046", "27479194"]}, {"Citation": "Soh P.N., Witkowski B., Olagnier D., Nicolau M.L., Garcia-Alvarez M.C., Berry A., Benoit-Vical F. In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob. Agents Chemother. 2009;53:1100\u20131106. doi: 10.1128/AAC.01175-08.", "ArticleIdList": ["10.1128/AAC.01175-08", "PMC2650562", "19015354"]}, {"Citation": "Park S.W., Kwon M.J., Yoo J.Y., Choi H.-J., Ahn Y.-J. Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses. BMC Complement. Altern. Med. 2014;14:171. doi: 10.1186/1472-6882-14-171.", "ArticleIdList": ["10.1186/1472-6882-14-171", "PMC4052798", "24885569"]}, {"Citation": "Promsong A., Chuenchitra T., Saipin K., Tewtrakul S., Panichayupakaranant P., Satthakarn S., Nittayananta W. Ellagic acid inhibits HIV-1 infection in vitro: Potential role as a novel microbicide. Oral Dis. 2018;24:249\u2013252. doi: 10.1111/odi.12835.", "ArticleIdList": ["10.1111/odi.12835", "29480632"]}, {"Citation": "Vilhelmova-Ilieva N., Jacquet R., Deffieux D., Pouys\u00e9gu L., Sylla T., Chassaing S., Nikolova I., Quideau S., Galabov A.S. Anti-Herpes Simplex Virus Type 1 Activity of Specially Selected Groups of Tannins. Drug Res. 2019;69:374. doi: 10.1055/a-0640-2557.", "ArticleIdList": ["10.1055/a-0640-2557", "30134445"]}, {"Citation": "Cui Q., Du R., Anantpadma M., Schafer A., Hou L., Tian J., Davey R.A., Cheng H., Rong L. Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor. Viruses. 2018;10:152. doi: 10.3390/v10040152.", "ArticleIdList": ["10.3390/v10040152", "PMC5923446", "29584652"]}, {"Citation": "Sundararajan A., Ganapathy R., Huan L., Dunlap J.R., Webby R.J., Kotwal G.J., Sangster M.Y. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antivir. Res. 2010;88:1\u20139. doi: 10.1016/j.antiviral.2010.06.014.", "ArticleIdList": ["10.1016/j.antiviral.2010.06.014", "PMC7114265", "20637243"]}, {"Citation": "Karimi A., Moradi M.-T., Rabiei M., Alidadi S. In vitro anti-adenoviral activities of ethanol extract, fractions, and main phenolic compounds of pomegranate (Punica granatum L.) peel. Antivir. Chem. Chemother. 2020;28:2040206620916571. doi: 10.1177/2040206620916571.", "ArticleIdList": ["10.1177/2040206620916571", "PMC7169357", "32306749"]}, {"Citation": "Acquadro S., Civra A., Cagliero C., Marengo A., Ritt\u00e0 M., Francese R., Sanna C., Bertea C., Sgorbini B., Lembo D., et al. Punica granatum Leaf Ethanolic Extract and Ellagic Acid as Inhibitors of Zika Virus Infection. Planta Med. 2020;86:1363\u20131374. doi: 10.1055/a-1232-5705.", "ArticleIdList": ["10.1055/a-1232-5705", "32937663"]}, {"Citation": "Pavlova E.L., Simeonova L.S., Gegova G.A. Combined efficacy of oseltamivir, isoprinosine and ellagic acid in influenza A(H3N2)-infected mice. Biomed Pharm. 2018;98:29\u201335. doi: 10.1016/j.biopha.2017.12.014.", "ArticleIdList": ["10.1016/j.biopha.2017.12.014", "29241072"]}, {"Citation": "Wojnarowicz J., Chudoba T., Gierlotka S., Lojkowski W. Effect of Microwave Radiation Power on the Size of Aggregates of ZnO NPs Prepared Using Microwave Solvothermal Synthesis. Nanomaterials. 2018;8:343. doi: 10.3390/nano8050343.", "ArticleIdList": ["10.3390/nano8050343", "PMC5977357", "29783651"]}, {"Citation": "Wojnarowicz J., Chudoba T., Koltsov I., Gierlotka S., Dworakowska S., Lojkowski W. Size control mechanism of ZnO nanoparticles obtained in microwave solvothermal synthesis. Nanotechnology. 2018;29:065601. doi: 10.1088/1361-6528/aaa0ef.", "ArticleIdList": ["10.1088/1361-6528/aaa0ef", "29231173"]}, {"Citation": "Hakeem A., Duan R., Zahid F., Dong C., Wang B., Hong F., Ou X., Jia Y., Lou X., Xia F. Dual stimuli-responsive nano-vehicles for controlled drug delivery: Mesoporous silica nanoparticles end-capped with natural chitosan. Chem. Commun. 2014;50:13268\u201313271. doi: 10.1039/C4CC04383A.", "ArticleIdList": ["10.1039/C4CC04383A", "25237679"]}, {"Citation": "Vichai V., Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 2006;1:1112\u20131116. doi: 10.1038/nprot.2006.179.", "ArticleIdList": ["10.1038/nprot.2006.179", "17406391"]}, {"Citation": "Song J.H., Choi H.J., Song H.H., Hong E.H., Lee B.R., Oh S.R., Choi K., Yeo S.G., Lee Y.P., Cho S., et al. Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3. J. Ginseng Res. 2014;38:173\u2013179. doi: 10.1016/j.jgr.2014.04.003.", "ArticleIdList": ["10.1016/j.jgr.2014.04.003", "PMC4213867", "25378991"]}, {"Citation": "Schuhmacher A., Reichling J., Schnitzler P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine. 2003;10:504\u2013510. doi: 10.1078/094471103322331467.", "ArticleIdList": ["10.1078/094471103322331467", "13678235"]}, {"Citation": "Malloy A. Count, size and visualize nanoparticles. Mater. Today. 2011;14:170\u2013173. doi: 10.1016/S1369-7021(11)70089-X.", "ArticleIdList": ["10.1016/S1369-7021(11)70089-X"]}, {"Citation": "Tang E., Cheng G., Ma X., Pang X., Zhao Q. Surface modification of zinc oxide nanoparticle by PMAA and its dispersion in aqueous system. Appl. Surf. Sci. 2006;252:5227\u20135232. doi: 10.1016/j.apsusc.2005.08.004.", "ArticleIdList": ["10.1016/j.apsusc.2005.08.004"]}, {"Citation": "Akbar N., Aslam Z., Siddiqui R., Shah M.R., Khan N.A. Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial molecules. AMB Express. 2021;11:104. doi: 10.1186/s13568-021-01261-1.", "ArticleIdList": ["10.1186/s13568-021-01261-1", "PMC8272778", "34245385"]}, {"Citation": "Luo M., Shen C., Feltis B.N., Martin L.L., Hughes A.E., Wright P.F.A., Turney T.W. Reducing ZnO nanoparticle cytotoxicity by surface modification. Nanoscale. 2014;6:5791\u20135798. doi: 10.1039/C4NR00458B.", "ArticleIdList": ["10.1039/C4NR00458B", "24740013"]}, {"Citation": "Halbus A.F., Horozov T.S., Paunov V.N. Surface-Modified Zinc Oxide Nanoparticles for Antialgal and Antiyeast Applications. ACS Appl. Nano Mater. 2020;3:440\u2013451. doi: 10.1021/acsanm.9b02045.", "ArticleIdList": ["10.1021/acsanm.9b02045"]}, {"Citation": "Hao L., Hu Y., Zhang Y., Wei W., Hou X., Guo Y., Hu X., Jiang D. Enhancing the mechanical performance of poly(ether ether ketone)/zinc oxide nanocomposites to provide promising biomaterials for trauma and orthopedic implants. RSC Adv. 2018;8:27304\u201327317. doi: 10.1039/C8RA01736K.", "ArticleIdList": ["10.1039/C8RA01736K", "PMC9083298", "35539979"]}, {"Citation": "Baghdadi Y.N., Youssef L., Bouhadir K., Harb M., Mustapha S., Patra D., Tehrani-Bagha A.R. The effects of modified zinc oxide nanoparticles on the mechanical/thermal properties of epoxy resin. J. Appl. Polym. Sci. 2020;137:49330. doi: 10.1002/app.49330.", "ArticleIdList": ["10.1002/app.49330"]}, {"Citation": "Feifel S.C., Lisdat F. Silica nanoparticles for the layer-by-layer assembly of fully electro-active cytochrome c multilayers. J. Nanobiotechnol. 2011;9:59. doi: 10.1186/1477-3155-9-59.", "ArticleIdList": ["10.1186/1477-3155-9-59", "PMC3278367", "22208693"]}, {"Citation": "Krishnan S., Raj C.J., Robert R., Ramanand A., Das S.J. Growth and characterization of succinic acid single crystals. Cryst. Res. Technol. 2007;42:1087\u20131090. doi: 10.1002/crat.200710981.", "ArticleIdList": ["10.1002/crat.200710981"]}, {"Citation": "Barahuie F., Hussein M.Z., Gani S.A., Fakurazi S., Zainal Z. Synthesis of protocatechuic acid\u2013zinc/aluminium\u2013layered double hydroxide nanocomposite as an anticancer nanodelivery system. J. Solid State Chem. 2015;221:21\u201331. doi: 10.1016/j.jssc.2014.09.001.", "ArticleIdList": ["10.1016/j.jssc.2014.09.001"]}, {"Citation": "Usman M.S., Hussein M.Z., Kura A.U., Fakurazi S., Masarudin M.J., Ahmad Saad F.F. Graphene Oxide as a Nanocarrier for a Theranostics Delivery System of Protocatechuic Acid and Gadolinium/Gold Nanoparticles. Molecules. 2018;23:500. doi: 10.3390/molecules23020500.", "ArticleIdList": ["10.3390/molecules23020500", "PMC6017407", "29495251"]}, {"Citation": "Parang K., El-Sayed N.S., Kazeminy A.J., Tiwari R.K. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E) Molecules. 2020;25:2343. doi: 10.3390/molecules25102343.", "ArticleIdList": ["10.3390/molecules25102343", "PMC7287735", "32429580"]}, {"Citation": "Cheng P.-W., Ng L.-T., Chiang L.-C., Lin C.-C. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 2006;33:612\u2013616. doi: 10.1111/j.1440-1681.2006.04415.x.", "ArticleIdList": ["10.1111/j.1440-1681.2006.04415.x", "PMC7162031", "16789928"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "18"}, {"Year": "2021", "Month": "12", "Day": "10"}, {"Year": "2021", "Month": "12", "Day": "12"}, {"Year": "2021", "Month": "12", "Day": "28", "Hour": "1", "Minute": "3"}, {"Year": "2021", "Month": "12", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "12", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["34959455", "PMC8706547", "10.3390/pharmaceutics13122174", "pharmaceutics13122174"]}}], "PubmedBookArticle": []}